The summary below is from the full report titled “Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and Alveolitis.” It is in the 20 June 2000 issue of Annals of Internal Medicine (volume 132, pages 947-954). The authors are B. White, W.C. Moore, F.M. Wigley, H.Q. Xiao, and R.A. Wise.
Cyclophosphamide To Treat Patients with Scleroderma Lung Disease. Ann Intern Med. 2000;132:947. doi: https://doi.org/10.7326/0003-4819-132-12-200006200-00044
Download citation file:
Published: Ann Intern Med. 2000;132(12):947.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use